B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
Completed · Phase 3
Conditions studied: HIV Infection, Hepatitis B
In brief
The purpose of this study was to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations of people living with HIV: prior HBV vaccine recipients who are deemed non-responders and individuals who are naïve to HBV vaccination.
Key facts
- Study ID
- NCT04193189
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 638
- Starts
- 2020-12-14
- Expected to finish
- 2024-08-13
- Last updated by the study team
- 2025-07-20
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alabama CRS — Birmingham, Alabama, United States
- UCLA CARE Center CRS — Los Angeles, California, United States
- UCSD Antiviral Research Center — San Diego, California, United States
- Ucsf Hiv/Aids Crs — San Francisco, California, United States
- Harbor-UCLA CRS — Torrance, California, United States
- University of Colorado Hospital CRS — Aurora, Colorado, United States
- Whitman-Walker Health CRS — Washington D.C., District of Columbia, United States
- The Ponce de Leon Center CRS — Atlanta, Georgia, United States
- Northwestern University CRS — Chicago, Illinois, United States
- Johns Hopkins University CRS — Baltimore, Maryland, United States
- Massachusetts General Hospital CRS (MGH CRS) — Boston, Massachusetts, United States
- Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS — Boston, Massachusetts, United States
- Washington University Therapeutics (WT) CRS — St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center CRS — Newark, New Jersey, United States
- Weill Cornell Chelsea CRS — New York, New York, United States
- Columbia P&S CRS — New York, New York, United States
- Weill Cornell Uptown CRS — New York, New York, United States
- University of Rochester Adult HIV Therapeutic Strategies Network CRS — Rochester, New York, United States
- Chapel Hill CRS — Chapel Hill, North Carolina, United States
- Greensboro CRS — Greensboro, North Carolina, United States
- Cincinnati Clinical Research Site — Cincinnati, Ohio, United States
- Case Clinical Research Site — Cleveland, Ohio, United States
- Ohio State University CRS — Columbus, Ohio, United States
- Penn Therapeutics CRS — Philadelphia, Pennsylvania, United States
- University of Pittsburgh CRS — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.